1. Home
  2. REG vs JAZZ Comparison

REG vs JAZZ Comparison

Compare REG & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regency Centers Corporation

REG

Regency Centers Corporation

HOLD

Current Price

$77.59

Market Cap

14.9B

Sector

Real Estate

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$256.64

Market Cap

16.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REG
JAZZ
Founded
1963
2003
Country
United States
Ireland
Employees
507
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9B
16.1B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
REG
JAZZ
Price
$77.59
$256.64
Analyst Decision
Buy
Strong Buy
Analyst Count
15
14
Target Price
$80.07
$217.57
AVG Volume (30 Days)
1.3M
697.4K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
3.80%
N/A
EPS Growth
N/A
N/A
EPS
N/A
7.17
Revenue
N/A
$1,618,693,000.00
Revenue This Year
$3.04
$6.22
Revenue Next Year
$4.52
$7.68
P/E Ratio
$26.85
$36.48
Revenue Growth
N/A
N/A
52 Week Low
$66.86
$109.87
52 Week High
$83.66
$265.05

Technical Indicators

Market Signals
Indicator
REG
JAZZ
Relative Strength Index (RSI) 42.61 65.75
Support Level $78.66 $222.49
Resistance Level $79.72 N/A
Average True Range (ATR) 1.27 7.12
MACD -0.37 0.46
Stochastic Oscillator 19.03 90.54

Price Performance

Historical Comparison
REG
JAZZ

About REG Regency Centers Corporation

Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 481 properties, which includes over 58 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: